Safety in Abdominal Aortic Aneurysm Surveillance Programs

Abdominal Aortic Aneurysm (AAA) rupture rate in the UK justifies the current surveillance programs and bring ease to some physicians that at some point have cast a shadow on their efficacy. This study also endorses reference thresholds to intervene patients.

El tratamiento endovascular parece superior a la cirugía en aneurismas rotosIn 2009, the UK National Health Service (NHS) implemented a AAA national surveillance scheme where men over 65 were eligible for screening. Those with ≥5.5 cm aneurysms were sent to consult with a vascular surgeon, while those with smaller aneurysms were invited to enter an ultrasound surveillance program.

 

AAA treatment guidelines were published in 2003, estimating a 3 to 15% rupture risk for aneurysms between 5 and 5.9 cm. More recent guidelines have estimated a 1% rupture risk a year for aneurysms under 5.5 cm.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


This study looked at over 18,000 men between 2009 and 2017 that took part in the surveillance scheme and starting with AAA between 3 and 5.5 cm. The study did not include women, since AAA incidence in women is significantly lower.

 

During the follow up period, some 1763 patients reached 5.5 cm or higher measures and were referred to a peripheral vascular physician for definite treatment. Some 83 with smaller aneurysms were also sent to a specialist based on their symptoms, rapid growth and other alarming signs. Finally, 31 patients had aneurysm rupture, and 29 of these patients died.

 

These figures result in an estimated risk of 1 in 100 patients/year for all diameters bellow 5.5 cm.


Read also: Risk of Colonic Ischemia after Abdominal Aortic Aneurysm Repair.


Risk is in direct correlation with diameter: it goes from 0.03% for smaller aneurysms (between 3 and 4.4 cm) to 0.4% for AAA right below the reference threshold (5.0 to 5.4 cm).

 

Since rupture risk in this cohort is so low, we can conclude that the surveillance program is safe.

 

Original title: Safety of men with small and medium abdominal aortic aneurysms under surveillance in the national health service screening program.

Reference: Oliver-Williams C et al. Circulation. 2019; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...